Skip to content

Released Nov 19, 2025, before the open

10-Q filed Nov 19, 2025, 50 days after period end · 0000868278-25-000017

Q3 2025 · 10-Q
Revenue$883.00K−37.6% vs Q3 2024−29.2% vs Q2 2025
Net Income-$6.84MN/M vs Q3 2024N/M vs Q2 2025
EPS Diluted-$0.16N/M vs Q3 2024N/M vs Q2 2025
Gross Profit-$123,000N/M
Operating Income-$4,764,000N/M
Operating Cash Flowderived-$3,486,000N/M
Free Cash Flowderived-$3,486,000N/M
Margins · derived
Gross margin-13.9%−29.1 pt vs Q3 2024
Operating margin-539.5%−81.9 pt vs Q3 2024
Net margin-774.5%−309.3 pt vs Q3 2024

What the release said

The release

Same quarter

MetricQ3 2025Q3 2024Q3 2023Q3 2022
Revenue$883.00K$1.42M$8.37M$24.20M
Net Income-$6.84M-$6.59M-$5.14M$968.00K
EPS Diluted-$0.16-$0.35-$0.30$0.06

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR